L.-H. Holle

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Systemic administration of strontium-89 is an important option for pain relief in advanced prostate carcinoma with multiple osseous metastases. Recently, rhenium-186-HEDP was introduced as a new substance which has important advantages (shorter physical half-life, scintigraphic imaging, dose distribution). The myelosuppressive effect can be estimated more(More)
  • 1